Travis Steed
Stock Analyst at B of A Securities
(0.31)
# 1777
Out of 5,291 analysts
94
Total ratings
45.00%
Success rate
5.17%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Penumbra | Initiates Coverage On: Buy | 320 | 266.95 | 19.87% | 1 | Mar 14, 2025 | |
Abbott Laboratories | Maintains: Strong Buy | 133 150 | 130.82 | 14.66% | 5 | Mar 10, 2025 | |
Solventum | Maintains: Neutral | 80 85 | 74.81 | 13.62% | 3 | Feb 26, 2025 | |
Becton Dickinson | Maintains: Overweight | 278 279 | 227.36 | 22.71% | 7 | Feb 14, 2025 | |
Edwards Lifesciences | Upgrades: Buy | 82 90 | 70.9 | 26.94% | 4 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | 19.51 | 64.02% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 45 | 33.76 | 33.29% | 5 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 480 45 | 12.51 | 259.71% | 1 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 315 | 364.44 | -13.57% | 4 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 365 295 | 258.63 | 14.06% | 3 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 | 18.39 | -13% | 5 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 51 28 | n/a | n/a | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 45 33 | 19.25 | 71.43% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 120 160 | 112.23 | 42.56% | 11 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 300 315 | 491.6 | -35.92% | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 335 275 | n/a | n/a | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 8 | 6.82 | 17.3% | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 25 | 12.29 | 103.42% | 1 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 85 | 17.66 | 381.31% | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 74 | n/a | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 125 | 67.69 | 84.67% | 7 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | n/a | n/a | n/a | 1 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 145 | 87.61 | 65.51% | 1 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 51 | 99.27 | -48.62% | 6 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 175 | 58.87 | 197.27% | 4 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 6 | n/a | n/a | 2 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 59 54 | 21.68 | 149.08% | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 22 | 96.16 | -77.12% | 1 | Jul 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 86 | n/a | n/a | 1 | Jun 30, 2017 |